On the afternoon of March 8, 2023, Dr. Qi Yu, chairman of Chengdu Xingenge Biotechnology Co., LTD. (hereinafter referred to as "Xingenge") and a group of 4 people visited Jinshi Technology Co., LTD. (hereinafter referred to as "Jinshi Technology") for exchange. 

At the meeting, Dr. Su Yunpeng, CEO of Science and technology, gave a detailed introduction to the participants on the company''s development history, product technology route and future industrial layout. Dr. Qi Yu, chairman of New Gene Grid, highly respected the craftsmanship spirit of Jinshi Technology focusing on the research and development and production of the new four-generation nanopore gene sequencer, and expressed the willingness to cooperate with Jinshi technology based on the professionalism of new gene Grid in the field of judicial identification and medical testing.

After the exchange, Dr. Su Yunpeng, CEO of Sci-Tech, led Dr. Qi Yu, chairman of Xingenge, and other people to visit some of the company''s laboratories, and introduced the work flow and sequencing chip of Gseq500, the first medium flux nanopore gene sequester independently developed by our company. Finally, Dr. Qi Yu said: Jinshi Technology and New Gene are both companies that focus on technological innovation, and have the same vision for the well-being of society. Their respective directions of focus represent two kinds of ecological industry chains. Through this exchange, the friendship between the two sides has been deepened and a good foundation has been laid for deeper cooperation in the future.